Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Sproull

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Cellular and Molecular Medicine|March 28, 2008
Post-collection, pre-measurement variables affecting VEGF levels in urine biospecimensRobert M Hayward, Melissa J Kirk, Mary Sproull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapyLinda W Chan, Marsha A Moses, Elizabeth Goley, et al.
Cancer Research|February 3, 2006
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysisCynthia Ménard, Donald Johann, Mark Lowenthal, et al.
Cancers|August 10, 2024
Serum CD133-Associated Proteins Identified by Machine Learning Are Connected to Neural Development, Cancer Pathways, and 12-Month Survival in GlioblastomaThomas Joyce, Erdal Tasci, Sarisha Jagasia, et al.
Biomarkers in Medicine|November 26, 2013
Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancerAlisa J Prager, Cynthia R Peng, Elena Lita, et al.
Biomolecules|October 28, 2023
Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care ChemoirradiationAndra V Krauze, Yingdong Zhao, Ming-Chung Li, et al.
International Journal of Molecular Sciences|October 26, 2024
MetaWise: Combined Feature Selection and Weighting Method to Link the Serum Metabolome to Treatment Response and Survival in GlioblastomaErdal Tasci, Michael Popa, Ying Zhuge, et al.
Frontiers in Oncology|August 28, 2023
Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panelAndra Valentina Krauze, Michael Sierk, Trinh Nguyen, et al.
Research Square|March 27, 2026
Temporal Integration of Serum Proteomics, Metabolomics and MRI Tumor Volumetrics via Deep Learning Identifies Systemic Mediators of Glioblastoma Response to ChemoradiotherapyAndra Krauze, Trinh Nguyen, Michael Sierk, et al.
Scientific Reports|January 5, 2023
Microarray analysis identifies coding and non-coding RNA markers of liver injury in whole body irradiated miceMolykutty J Aryankalayil, Michelle A Bylicky, Shannon Martello, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Cellular and Molecular Medicine|March 28, 2008
Post-collection, pre-measurement variables affecting VEGF levels in urine biospecimensRobert M Hayward, Melissa J Kirk, Mary Sproull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapyLinda W Chan, Marsha A Moses, Elizabeth Goley, et al.
Cancer Research|February 3, 2006
Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysisCynthia Ménard, Donald Johann, Mark Lowenthal, et al.
Cancers|August 10, 2024
Serum CD133-Associated Proteins Identified by Machine Learning Are Connected to Neural Development, Cancer Pathways, and 12-Month Survival in GlioblastomaThomas Joyce, Erdal Tasci, Sarisha Jagasia, et al.
Biomarkers in Medicine|November 26, 2013
Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancerAlisa J Prager, Cynthia R Peng, Elena Lita, et al.
Biomolecules|October 28, 2023
Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care ChemoirradiationAndra V Krauze, Yingdong Zhao, Ming-Chung Li, et al.
International Journal of Molecular Sciences|October 26, 2024
MetaWise: Combined Feature Selection and Weighting Method to Link the Serum Metabolome to Treatment Response and Survival in GlioblastomaErdal Tasci, Michael Popa, Ying Zhuge, et al.
Frontiers in Oncology|August 28, 2023
Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panelAndra Valentina Krauze, Michael Sierk, Trinh Nguyen, et al.
Research Square|March 27, 2026
Temporal Integration of Serum Proteomics, Metabolomics and MRI Tumor Volumetrics via Deep Learning Identifies Systemic Mediators of Glioblastoma Response to ChemoradiotherapyAndra Krauze, Trinh Nguyen, Michael Sierk, et al.
Scientific Reports|January 5, 2023
Microarray analysis identifies coding and non-coding RNA markers of liver injury in whole body irradiated miceMolykutty J Aryankalayil, Michelle A Bylicky, Shannon Martello, et al.
Pageof 5